Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A gestational diabetes smartphone app developed in collaboration with Oxford University Hospitals NHS Trust and University of Oxford's department of biomedical engineering has won an award.

Dr Lucy MacKillop (Nuffield Department of Obstetrics & Gynaecology) and Katy Bartlett (John Radcliffe Hospital) receive the QiC award for 'best digital initiative' © University of Oxford
Dr Lucy MacKillop (Nuffield Department of Obstetrics & Gynaecology) and Katy Bartlett (John Radcliffe Hospital) receive the QiC award for 'best digital initiative'

A project which has harnessed technology to improve care for women who develop diabetes during pregnancy has won a national prize. The team behind GDm-health – the gestational diabetes smartphone app – received the Best Digital Initiative trophy at the Quality in Care Diabetes Awards.

The technology was developed – with patient input – by Professor Lionel Tarassenko, Professor of Electrical Engineering and Head of Engineering Science at the University of Oxford and his research group.

The project is a collaboration between Oxford University Hospitals and the University of Oxford, funded by the Oxford Biomedical Research Centre. Professor Tarassenko said: “Our digital health work (smartphone apps for managing your health) has now been shown to be clinically useful. This outcome has only been possible because of the partnership between engineers and clinicians that exists in Oxford”.

Every year hundreds of women due to give birth at the John Radcliffe develop gestational diabetes – it affects about one in ten pregnancies, but that figure is rising.

The conventional treatment is for the patient to manage and record their blood glucose levels up to six times a day with their medication dose adjusted on fortnightly check-ups in hospital. The smartphone app enables diabetes specialists to keep closer tabs on their patients – while reducing the number of tiring, time-consuming and expensive hospital appointments.

This is a fantastic accolade and an excellent example of innovative and successful collaboration between the university and hospital. It is also a fabulous boost for our wonderful team and all their hard work”.
Dr Lucy Mackillop, Consultant Obstetric Physician based at the John Radcliffe Women’s Centre

Katy Bartlett, Lead Diabetic Midwife, said: “The success of this project has exceeded our expectations which is fantastic”.

Vanessa Galli-Wara, of Calvert, near Buckingham, was diagnosed with gestational diabetes towards the end of her first pregnancy. She used the new device to monitor her blood sugar levels and pass on comments to the team at the JR. Vanessa made adjustments to her diet based on regular feedback from diabetes specialist midwife Katy Bartlett. Vanessa’s daughter Harriet Poppy was born fit and well on 11th November 2014 .

Vanessa said: “It was handy to know that I was in constant touch with somebody and that I would get a message if there was something to worry about. Katy was very kind and helpful.

“Without the kit I wouldn’t have known my results and what my diet was doing to my levels. I would have had to follow a more rigid diet. We live about an hour away so having fewer appointments as a result of using this kit helped a lot”.
Successful pilot project

Following the success of the pilot project in Oxford, the initiative is now being introduced at other hospitals, thanks to the Oxford Academic Health Science Network. A full randomised trial is also under way. Two hundred women are taking part in this and results should be published next year.


Similar stories

How do unborn babies and mothers communicate via the placenta?

DPhil student Neva Kandzija wins an Oxford Sparks competition to have her Placenta research transformed into a two minute animation film for free.

100 000 babies screened for increased type 1 diabetes risk in the INGR1D Study

Celebrating a major milestone for one of Europe’s biggest type 1 diabetes research cooperations: The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has successfully screened 100,000 newborns across Europe (including over 7500 newborns in the Thames Valley) for an increased genetic risk of developing type 1 diabetes.

Vatish Group Win UNIVANTS of Healthcare Excellence Award

Dr Manu Vatish and Dr Sofia Cerdeira from the Nuffield Department of Women's and Reproductive Health have won a prestigious global award, that recognises teams that collaborate across disciplines and transform healthcare delivery and ultimately patient lives.

Innovative exosome research aims to create new technology that will predict Pre-eclampsia

JVCKENWOOD launches joint research with Oxford University and Sysmex R&D Center Europe GmbH to establish a system for predicting the onset of Pre-eclampsia using exosomes.

Pregnant women to help test vaccine against childhood virus

Pregnant women receiving antenatal care in the Women’s Centre at Oxford’s John Radcliffe Hospital may be asked to take part in a world-first clinical trial to find a vaccine against a common and potentially serious viral infection in babies.

Honour for George Institute UK Executive Director

Executive Director of The George Institute, UK, Professor Terry Dwyer has been awarded an honorary doctorate by Trinity College Dublin for his extensive work in child health.